A Long-Overdue Change in Women’s Health
After years of discussion within the medical and research community, polycystic ovarian syndrome (PCOS) is officially being renamed polyendocrine metabolic ovarian syndrome (PMOS).
At first glance, it might sound like a small administrative update. A tweak in medical language. But this change is actually deeply significant for many women.
Including me.
I was diagnosed with PCOS as a teenager because I was in a larger body and an ultrasound showed “polycystic ovaries.” Later, I learned that this ovarian appearance can actually be very common in teenage girls and does not automatically mean someone has a lifelong endocrine condition.
But at the time, that distinction wasn’t explained to me.
What I took away from that diagnosis was fear. Fear that my body was somehow failing me. Fear that having children might be difficult or even impossible. Fear that my body was something I needed to “fix.” When you’re young, those messages can shape the way you see yourself for years. For me, it absolutely changed the way I thought about having children and my future health. That’s part of why this name change matters so much.
The problem with the term “PCOS”
The name polycystic ovarian syndrome has always been misleading. Firstly, many women diagnosed with PCOS do not actually have ovarian cysts. The follicles seen on ultrasound are not ovarian cysts in the traditional medical sense, yet the terminology has caused decades of confusion. Secondly, the name focuses heavily on the ovaries, when this condition is often far more systemic.
PCOS can involve insulin resistance, metabolic dysfunction, changes in appetite regulation, acne, irregular cycles, fertility challenges, cardiovascular risk, fatigue, and significant impacts on mental health and body image. Some women primarily experience reproductive symptoms. Others experience predominantly metabolic symptoms. Many experience both. Yet the old name narrowed the conversation down to ovaries and fertility. For many women, especially young women, that can feel incredibly loaded.
What the new name means
The updated term, polyendocrine metabolic ovarian syndrome, aims to better reflect the condition’s broader nature:
- “Polyendocrine” acknowledges that multiple hormone systems are involved, not just reproductive hormones.
- The inclusion of the word “metabolic” acknowledges that this condition can affect far more than fertility or periods
- It reflects the broader impacts PMOS can have on things like blood sugar regulation, insulin sensitivity, energy, weight, and long-term health.
- Ovarian keeps ovarian function within the picture, without making it the sole focus.
It’s not a perfect name. Most medical names aren’t. But it is a far more accurate representation of what clinicians and researchers now understand this condition to be.
Why this change matters emotionally, too.
Language in healthcare matters.
A diagnosis is never just clinical information. It often becomes part of someone’s identity, especially when they receive it at a young age. For years, many women have walked away from a PCOS diagnosis carrying fear, shame, confusion, or the belief that their body is somehow failing them. Some became hyper-focused on fertility before they were even sure they wanted children. Some felt dismissed because they didn’t “look” like the typical PCOS patient. Some spent years trying to understand symptoms that nobody had properly connected. And some, like me, internalised the diagnosis in ways that quietly shaped major life decisions.
That deserves acknowledgment. A more complete approach to women’s health.
One of the positives of this shift is that it encourages a more holistic understanding of women’s health. This condition has never been just about fertility. And support should never stop at symptom suppression. Women deserve care that looks at the full picture of their health, not just their fertility or the number on the scale. We deserve practitioners who are willing to listen properly, explain what is happening in our bodies, and provide realistic, supportive strategies that improve both current symptoms and long-term health.
Will changing the name fix everything?
No. A new name alone won’t suddenly eliminate medical bias, improve healthcare accessibility, or solve the gaps that still exist in women’s health research. But it does represent progress. It reflects a growing understanding that women’s health conditions are often more complex, more systemic, and more nuanced than they have historically been treated. And perhaps most importantly, it opens the door for future generations of girls to receive explanations that are clearer, more accurate, and hopefully far less frightening than many of us received.
Final thoughts
For many women, this change feels validating. It acknowledges that the condition has always been more complex than the old name suggested, and that their experiences extend far beyond their ovaries. PMOS may take some getting used to, but the intention behind the change is clear: to create a more accurate, less misleading, and more comprehensive understanding of a condition that has been misunderstood for far too long.
Have you been diagnosed with PMOS (or PCOS) & want to really understand what’s happening in your body?
As a Clinical Nutritionist passionate about supporting women across the lifespan I can help you to understand how to manage PMOS and how to support yourself holistically with this condition. By looking at supporting your diet, lifestyle & using high-quality supplements where indicated, we can work together to support your hormonal and metabolic health. Book in for a free discovery call with me here & let’s take the next step together.
Want to stay in touch?
Join our mailing list by simply scrolling to the bottom of the home page & entering your details. This will keep you up to date with new blogs, specials on the online store, new webinars & our monthly email includes a monthly health and wellness tip.
Follow us on Instagram & FaceBook.
Disclaimer: This content is for educational purposes only and does not replace personalised medical advice. Always consult a qualified practitioner before beginning any new treatment.
References
Taieb, A., Asma, G., Jabeur, M., Fatma, B. A., Nassim, B. H. S., & Asma, B. A. (2024). Rethinking the terminology: A perspective on renaming polycystic ovary syndrome for an enhanced pathophysiological understanding. Clinical Medicine Insights: Endocrinology and Diabetes, 17, 1-11. https://doi.org/10.1177/11795514241296777
Teede, H. J., Bahri Khomami, M., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., & Piltonen, T. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process. The Lancet. Advance online publication. https://doi.org/10.1016/S0140-6736(26)00717-8
